Cancer Epidemiology
Volume 34, Issue 3 , Pages 262-266 , June 2010

Problems in assessing multiple cutaneous melanoma. A review on the accuracy of a population based cancer registry

  • Anna Måsbäck

      Affiliations

    • Department of Pathology and Cytology, University Hospital Lund, Sweden
    • Corresponding Author InformationCorresponding author at: Lund University, University and Regional Laboratories, University Hospital, Department of Pathology, SE 221 85 Lund, Sweden. Tel.: +46 46 173510; fax: +46 46 143307.
    • ,
  • Gertrud Andersson

      Affiliations

    • Regional Tumour Registry, University Hospital Lund, Sweden
    • ,
  • Håkan Olsson

      Affiliations

    • Department of Oncology and Cancer Epidemiology, University Hospital Lund, Sweden

,Accepted 27 February 2010.

References 

  1. Borg A, Sandberg T, Nilsson K, Johannsson O, Klinker M, Måsbäck A, et al. High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families. J Natl Cancer Inst. 2000;92:1260–1266
  2. Mattsson B, Rutqvist LE, Wallgren A. Undernotification of diagnosed cancer cases to the Stockholm cancer registry. Int J Epidemiol. 1985;14(1):64–69
  3. Barlow L, Westergren K, Holmberg L, Talbäck M. The completeness of the Swedish Cancer Registry: a sample survey for year 1998. Acta Oncol. 2009;48:27–33
  4. Lindblad M, Ye W, Lindgren A, Lagergren J. Disparities in the classification of esophageal and cardia adenocarcinomas and their influence on reported incidence rates. Ann Surg. 2006;243:479–485
  5. Busam KJ, Barnhill RL. Metastatic malignant melanoma. In:  Barnhill RL editors. Pathology of melanocytic nevi and malignant melanoma. 2nd ed.. New York: Springer–Verlag; 2004;p. 357–371
  6. Abernethy JL, Soyer HP, Kerl H, Jorizzo JL, White WL. Epidermotropic metastatic malignant melanoma simulating melanoma in situ. A report of 10 examples from two patients. Am J Surg Pathol. 1994;18:1140–1149
  7. Tucker SB, Hortmann JP, Hertel B, Aranha G, Rosai J. Activation of nevi in patients with malignant melanoma. Cancer. 1980;46:822–827
  8. Palmieri G, Cossu A, Ascierto PA, Botti G, Strazzullo M, Lissia A, et al. Definition of the role of chromosome 9p21 in sporadic melanoma through genetic analysis of primary tumours and their metastases. The Melanoma Cooperative Group. Br J Cancer. 2000;83:1707–1714
  9. Lindgren D, Gudjonsson S, Ja Jee K, Liedberg F, Aits S, Andersson A, et al. Recurrent and multiple bladder tumors show conserved expression profiles. BMC Cancer 2008;8:183. www.biomedcentral.com/1471-2407/8/183.
  10. Texeira MR, Pandis N, Heim S. Cytogenetic clues to breat carcinogenesis. Genes Chromosomes Cancer. 2002;33:1–16
  11. Braakhuis BJ, Tabor MP, Leemans CR, van der Waal I, Snow GB, Brakenhoff RH. Second primary tumours and field cancerization in oral and oropharyngeal cancer: molecular techniques provide new insights and definitions. Head Neck. 2002;24(2):198–206
  12. Borg Å, Johansson U, Johannsson O, Håkansson S, Weterdahl J, Måsbäck A, et al. Novel germline p16 mutation in familial malignant melanoma in South Sweden. Cancer Res. 1996;56:2497–2500
  13. Giles G, Staples M, McCredle M, Coates M. Multiple primary melanomas: an analysis of cancer registry data from Victoria and New South Wales. Melanoma Res. 1995;5:433–438

☆ Grants: The Swedish Cancer Society, Skane county council's research and development foundation.

PII: S1877-7821(10)00033-0

doi: 10.1016/j.canep.2010.02.014

Cancer Epidemiology
Volume 34, Issue 3 , Pages 262-266 , June 2010

Article Tools

* Image Usage & Resolution